Jeffery R. Sawyer
Professor
faculty
Pathology, College of Medicine
10 h-index
56 pubs
675 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jeffery R. Sawyer's research focuses on the cytogenetic and phenotypic markers associated with multiple myeloma and monoclonal gammopathy of unknown significance. His work investigates how specific chromosomal alterations, such as deletions of the short arm (1p13.3) and gains or amplifications of chromosome 1q (1q21), impact patient outcomes. Sawyer has published on the correlation between these genetic abnormalities and poor clinical prognosis in multiple myeloma, utilizing techniques like fluorescence in situ hybridization (FISH) and eight-color flow cytometry. His publications also explore the progression of monoclonal gammopathy of unknown significance in relation to phenotypic markers. Sawyer holds an h-index of 10 with 56 total publications and 672 citations. He has collaborated with researchers including Fenghuang Zhan and Erming Tian at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 10
- Publications: 56
- Citations: 675
Selected Publications
-
Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes (2024)
-
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma (2023)
-
Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome (2021)
-
Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance (2021)
Grants & Funding
- DNA Hypomethylation and Cancer NIH/Nat. Cancer Institute Principal Investigator
- DNA Hypomethylation and Cancer NIH/Nat. Cancer Institute Principal Investigator
Collaboration Network
Top Collaborators
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
4 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
- Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
Carolina Schinke
Winthrop Rockefeller Foundation
4 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
- Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
Frits van Rhee
Winthrop Rockefeller Foundation
4 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
- Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
Maurizio Zangari
Winthrop Rockefeller Foundation
4 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
- Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
Meera Mohan
Medical College of Wisconsin (US)
3 shared publications
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Daisy Alapat
University of Arkansas for Medical Sciences (US)
3 shared publications
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Erming Tian
Winthrop Rockefeller Foundation
3 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Fenghuang Zhan
Winthrop Rockefeller Foundation
3 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Guido Tricot
Winthrop Rockefeller Foundation
2 shared publications
In database
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Zimu Gong
Texas Oncology (US)
2 shared publications
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Concomitant Deletion of Short Arm (del 1p) and Amplification or Gain (1q21) of Chromosome 1 By Fluorescence in Situ Hybridization (FISH) Is Associated with Poor Clinical Outcome
Samer Al Hadidi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
- Impact of Additional Chromosome 1q Copies on Multiple Myeloma Survival Outcomes
Naveen Yarlagadda
1 shared publication
In database
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Shebli Atrash
Levine Cancer Institute (US)
1 shared publication
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
1 shared publication
In database
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Shadiqul Hoque
Winthrop Rockefeller Foundation (US)
1 shared publication
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Similar Researchers
Based on overlapping research topics
Sarah K. Johnson
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
W. Newton Suter
University of Arkansas at Little Rock
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Molecular Biology Techniques and Applications
Hongwei Xu
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Genomics and Diagnostics
Molecular Biology Techniques and Applications
Fritz Van Rhee
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Penelope Duerken-Hughes
National Center for Toxicological Research
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Molecular Biology Techniques and Applications
Meei Liu
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Molecular Biology Techniques and Applications